학술논문

Phase III randomized trial of stereotactic ablative radiotherapy (SAbR) for oligometastatic advanced renal carcinoma (EA8211-SOAR).
Document Type
Article
Source
Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, pTPS489-TPS489, 140p
Subject
Language
ISSN
0732183X